GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Dividend Yield %

Nuvation Bio (Nuvation Bio) Dividend Yield % : 0.00% (As of Apr. 27, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Dividend Yield %?

As of today (2024-04-27), the Trailing Annual Dividend Yield of Nuvation Bio is 0.00%.

The historical rank and industry rank for Nuvation Bio's Dividend Yield % or its related term are showing as below:

NUVB's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.58
* Ranked among companies with meaningful Dividend Yield % only.

Nuvation Bio's Dividend Payout Ratio for the three months ended in Sep. 2021 was 0.00.

As of today (2024-04-27), the Forward Dividend Yield % of Nuvation Bio is 0.00%.

Nuvation Bio's Dividends per Share for the three months ended in Sep. 2021 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Nuvation Bio Dividend Yield % Historical Data

The historical data trend for Nuvation Bio's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Dividend Yield % Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Dividend Yield %
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Dividend Yield % Get a 7-Day Free Trial - - - - -

Competitive Comparison of Nuvation Bio's Dividend Yield %

For the Biotechnology subindustry, Nuvation Bio's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nuvation Bio's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Dividend Yield % falls into.



Nuvation Bio Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Nuvation Bio  (NYSE:NUVB) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Nuvation Bio Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.